Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

160 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Humoral and T-Cell Immune Response After 3 Doses of Messenger RNA Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines in Fragile Patients: The Italian VAX4FRAIL Study.
Corradini P, Agrati C, Apolone G, Mantovani A, Giannarelli D, Marasco V, Bordoni V, Sacchi A, Matusali G, Salvarani C, Zinzani PL, Mantegazza R, Tagliavini F, Lupo-Stanghellini MT, Ciceri F, Damian S, Uccelli A, Fenoglio D, Silvestris N, Baldanti F, Piaggio G, Ciliberto G, Morrone A, Locatelli F, Sinno V, Rescigno M, Costantini M; VAX4FRAIL Study Group. Corradini P, et al. Among authors: fenoglio d. Clin Infect Dis. 2023 Feb 8;76(3):e426-e438. doi: 10.1093/cid/ciac404. Clin Infect Dis. 2023. PMID: 35607769 Free PMC article.
Fingolimod modulates peripheral effector and regulatory T cells in MS patients.
Serpero LD, Filaci G, Parodi A, Battaglia F, Kalli F, Brogi D, Mancardi GL, Uccelli A, Fenoglio D. Serpero LD, et al. Among authors: fenoglio d. J Neuroimmune Pharmacol. 2013 Dec;8(5):1106-13. doi: 10.1007/s11481-013-9465-5. Epub 2013 May 7. J Neuroimmune Pharmacol. 2013. PMID: 23649711 Free PMC article.
COVID-19 Vaccination in Fragile Patients: Current Evidence and an Harmonized Transdisease Trial.
Agrati C, Di Cosimo S, Fenoglio D, Apolone G, Ciceri F, Ciliberto G, Baldanti F, Costantini M, Giannarelli D, Ippolito G, Locatelli F, Mantovani A, Morrone A, Tagliavini F, Uccelli A, Zinzani PL, Silvestris N, Rescigno M. Agrati C, et al. Among authors: fenoglio d. Front Immunol. 2021 Aug 10;12:704110. doi: 10.3389/fimmu.2021.704110. eCollection 2021. Front Immunol. 2021. PMID: 34447374 Free PMC article.
The Longest Persistence of Viable SARS-CoV-2 With Recurrence of Viremia and Relapsing Symptomatic COVID-19 in an Immunocompromised Patient-A Case Study.
Sepulcri C, Dentone C, Mikulska M, Bruzzone B, Lai A, Fenoglio D, Bozzano F, Bergna A, Parodi A, Altosole T, Delfino E, Bartalucci G, Orsi A, Di Biagio A, Zehender G, Ballerini F, Bonora S, Sette A, De Palma R, Silvestri G, De Maria A, Bassetti M. Sepulcri C, et al. Among authors: fenoglio d. Open Forum Infect Dis. 2021 Apr 28;8(11):ofab217. doi: 10.1093/ofid/ofab217. eCollection 2021 Nov. Open Forum Infect Dis. 2021. PMID: 34796242 Free PMC article.
Healthcare Worker Study Cohort to Determine the Level and Durability of Cellular and Humoral Immune Responses after Two Doses of SARS-CoV-2 Vaccination.
Dentone C, Fenoglio D, Ponzano M, Cerchiaro M, Altosole T, Franciotta D, Portunato F, Mikulska M, Taramasso L, Magnasco L, Uras C, Magne F, Ferrera F, Scavone G, Signori A, Vena A, Visconti V, Filaci G, Sette A, Grifoni A, Di Biagio A, Bassetti M. Dentone C, et al. Among authors: fenoglio d. Vaccines (Basel). 2022 Oct 24;10(11):1784. doi: 10.3390/vaccines10111784. Vaccines (Basel). 2022. PMID: 36366293 Free PMC article.
160 results